Tivic Health Systems, Inc. Common Stock (TIVC) is a publicly traded Healthcare sector company. As of May 21, 2026, TIVC trades at $1.40 with a market cap of $4.03M and a P/E ratio of -0.18. TIVC moved +7.69% today. Year to date, TIVC is -39.91%; over the trailing twelve months it is -80.34%. Its 52-week range spans $0.72 to $15.64. Rallies surfaces TIVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Valion Bio Rebrands, Ticker VBIO, Poised for Nine-Figure BARDA Contract: Valion Bio, formerly Tivic Health Systems, will adopt the ticker VBIO on April 28, 2026, marking its shift to a late-stage biopharmaceutical company. Its lead candidate Entolimod™, backed by over $140 million in development and key FDA designations, targets a nine-figure BARDA procurement contract and oncology supportive care trials.
| Metric | Value |
|---|---|
| Price | $1.40 |
| Market Cap | $4.03M |
| P/E Ratio | -0.18 |
| EPS | $-7.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.64 |
| 52-Week Low | $0.72 |
| Volume | 352.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $-70.00K |
| Net Income | $-13.58M |
| Gross Margin | 0.00% |
TIVC analyst coverage data. Average price target: $0.00.